Junneng Chemicals India Profile
Key Indicators
- Authorised Capital ₹ 33.72 Cr
as on 04-07-2024
- Paid Up Capital ₹ 15.05 Cr
as on 04-07-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 22794.97%
(FY 2023)
- Profit 3353.59%
(FY 2023)
- Ebitda -674.42%
(FY 2023)
- Net Worth 38.47%
(FY 2023)
- Total Assets 39.20%
(FY 2023)
About Junneng Chemicals India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 33.72 Cr and a paid-up capital of Rs 15.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Junneng Chemicals India Private Limited India is Navya Makhijani as COMPANY SECRETARY. Lata Nankani, Yuanting Wang, and Naxin Li serve as directors at the Company.
- CIN/LLPIN
U24303GJ2016FTC094689
- Company No.
094689
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
14 Dec 2016
- Date of AGM
29 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Junneng Chemicals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Navya Makhijani | Company Secretary | 08-Apr-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lata Nankani  | Director | 30-Sep-2019 | Current |
Yuanting Wang  | Director | 16-Aug-2017 | Current |
| Naxin Li | Director | 14-Dec-2016 | Current |
Financial Performance of Junneng Chemicals India.
Junneng Chemicals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22794.97% increase. The company also saw a substantial improvement in profitability, with a 3353.59% increase in profit. The company's net worth Soared by an impressive increase of 38.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Junneng Chemicals India?
In 2023, Junneng Chemicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Junneng Chemicals India?
Unlock and access historical data on people associated with Junneng Chemicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Junneng Chemicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Junneng Chemicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
